2022
DOI: 10.1227/neu.0000000000002134
|View full text |Cite
|
Sign up to set email alerts
|

Neurostimulation for Functional Recovery After Traumatic Brain Injury: Current Evidence and Future Directions for Invasive Surgical Approaches

Abstract: We aim to provide a comprehensive review of the current scientific evidence supporting the use of invasive neurostimulation in the treatment of deficits associated with traumatic brain injury (TBI), as well as to identify future directions for research and highlight important questions that remain unaddressed. Neurostimulation is a treatment modality with expanding applications in modern medical practice. Targeted electrical stimulation of specific brain regions has been shown to increase synaptogenesis and en… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 72 publications
0
2
0
Order By: Relevance
“…Recent evidence points to functional improvement in patients after TBI using neuromodulation ( Tiefenbach et al, 2022 ). Improvements in motor function after TBI using functional electrical stimulation have been demonstrated through the reorganization of cortical areas ( Milosevic et al, 2021 ).…”
Section: Pathophysiology Of Pth and Associated Mechanisms After Tbimentioning
confidence: 99%
“…Recent evidence points to functional improvement in patients after TBI using neuromodulation ( Tiefenbach et al, 2022 ). Improvements in motor function after TBI using functional electrical stimulation have been demonstrated through the reorganization of cortical areas ( Milosevic et al, 2021 ).…”
Section: Pathophysiology Of Pth and Associated Mechanisms After Tbimentioning
confidence: 99%
“…The procedure is currently US Food and Drug Administration (FDA) approved for the treatment of Parkinson’s disease [6], essential tremor [6], and refractory epilepsy [7], while also having humanitarian device exemption status for primary dystonia [8] and obsessive-compulsive disorder [9]. Furthermore, DBS is undergoing active clinical evaluation for a range of other conditions, including Tourette’s syndrome [10], depression [11], chronic cluster headache [12], multiple sclerosis [13], stroke recovery [14], traumatic brain injury [15], and hypertension [16].…”
Section: Introductionmentioning
confidence: 99%